MI
Milestone Pharmaceuticals Inc.
MIST · NASDAQ
$0.93 -4.36% (-$0.04)
1M -13.69%
Market Cap $115.5M
P/E Ratio -
Div. Yield -
ROE 288.36%
Bulios Fair Price
$0.77
17.0% downside
Trenutna cena
$0.93
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica MIST trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
11 /100
Expensive P/B 6.34x
P/S 49.29x
P/FFO N/A
Growth
0 /100
Declining Book val. growth 14.29%
Rev. growth 32.38%
FCF growth N/A
Profitability
20 /100
Weak Net margin 3,585.62%
Op. margin 3,353.01%
FCF margin 2,612.73%
Quality
0 /100
Poor ROE 288.36%
ROA 46.26%
Asset turnover 0.01x
Debt
23 /100
High Current ratio 8.13x
Int. coverage -6.79x
Debt/Equity 3.30x
Stability
59 /100
Moderate EPS volatility 34.50%
Profitable years 0
Beta 0.98x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MIST
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Joseph G. Oliveto
Employees
38
Headquarters
Montreal
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report